This is the protocol for a review and there is no abstract. The objectives are as follows:
To provide an overview of the benefits and harms of interventions for neovascular AMD as measured 12 months after the start of treatment.
To consider the longer term effects of these interventions (after 24 months).
To identify gaps in the evidence.